# Scientific objective

Study neutral N-allyl gem-difluoroenamine Int1 and independently determine whether the authors' proposed catalyst-free molecular route—initial intramolecular attack forming an open-shell diradical, followed by C–C closure—is consistent with computed energetics. Compare it with the alternative aza-Claisen rearrangement. Report the overall Gibbs free-energy barrier from Int1 for the [2+2] route, the lowest aza-Claisen barrier, their difference, and the preferred pathway.

# Public inputs and scientific boundaries

The public molecule is in `data/inputs/int1.smi`, with neutral charge and the connectivity encoded there; `problem_definition.json` defines solvent, temperature, standard state, multiplicity options, pathway endpoints and observables. The system boundary is one isolated Int1 molecule in implicit toluene at 298.15 K. Do not use the paper, SI or general web. You may choose software, model chemistry, conformer strategy and execution order. Do not treat an unverified TS or a single conformer as established.

# Required scientific validation/investigation

Generate and deduplicate a defensible set of Int1 conformers and candidate stationary points for both named pathways. Advance candidates only when their connectivity matches the pathway definition. Validate minima and TSs with frequencies; validate electronic state/wavefunction stability or an explicitly justified spin diagnostic; validate critical TS connectivity with IRC or a clearly justified equivalent. Compute solution-standard-state Gibbs barriers consistently and report conformer/candidate coverage. The calculation is complete when both pathway barriers have a selected, validated stationary-point chain or a bounded-failure explanation naming the missing validation. Stop when additional starting conformers no longer produce a distinct lower validated pathway candidate, and report that stopping basis.

# Deliverables

Submit `report/results.json` following the schema. Use the public pathway identifiers `cycloaddition` and `aza_claisen` in the pathway records and identify every selected stationary point by a neutral structural/coordinate description, not a paper-internal label. Include method, conformer/candidate counts, per-pathway selected TS identity and validation evidence, numeric barriers in kcal/mol when available, barrier difference, preferred pathway, uncertainty/limitations, and a completion status. A bounded failure must retain truthful attempted-candidate records and explain which route or validation could not be completed; unavailable barriers and comparisons must be reported as null rather than invented numbers.
